Rothschild Investment »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Rothschild Investment

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2025-09-30 $880 1.0k 0.88
2025-06-30 $720 1.0k 0.72
2025-03-31 $929 1.0k 0.93
2024-12-31 $1.1k 1.0k 1.10
2024-09-30 $1.1k 1.0k 1.13
2024-06-30 $1.3k 1.0k 1.29

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Jpmorgan Chase & Co Stock (JPM)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Blackstone Stock (BX)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Invesco Rafi Us 1000 Etf Etf (PRF)
Amazon Stock (AMZN)
Abbvie Stock (ABBV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Meta Platforms Inc Cl A Stock (META)
Oracle Corp Stock (ORCL)
Chevron Corp Stock (CVX)
Costco Whsl Corp Stock (COST)

View all positions for Rothschild Investment

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1